NEW YORK (GenomeWeb) – PerkinElmer reduced its headcount by 191 people, it said in a Form 10-K filed with the US Securities and Exchange Commission.

The firm went through several headcount reductions in 2014 and laid off 17 employees in Q1, 22 employees in Q2, and 152 employees in Q3. As a result, PerkinElmer took severance charges of $14.4 M for the year. In 2013, PerkinElmer cut its workforce by 430 people.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.